Compare Neurocrine Biosciences Inc (NBIX) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Ferrari NV — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Ferrari NV trades at $367.23 (market cap $65.48B). The key difference: Ferrari NV is far larger — about 3.8× Neurocrine Biosciences Inc's market cap, and Ferrari NV pays a 1.14% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | RACE | |
|---|---|---|
Market Cap | $17.40B | $65.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $180.55 | $517.65 |
52-Week Low | $123.10 | $314.63 |
Enterprise Value | $16.49B | $66.69B |
Dividend Yield | — | 1.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
